Eiken Chemical Co., Ltd. (4549.T)
JPY 2165.0
(0.42%)
JPY 2165.0
(0.42%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 5.7 Billion JPY | -41.32% |
| 2022 | 9.58 Billion JPY | -8.04% |
| 2021 | 10.44 Billion JPY | 24.01% |
| 2020 | 8.32 Billion JPY | 34.18% |
| 2019 | 6.25 Billion JPY | 1.02% |
| 2018 | 6.19 Billion JPY | 20.38% |
| 2017 | 5.13 Billion JPY | -7.62% |
| 2016 | 5.53 Billion JPY | 12.69% |
| 2015 | 4.95 Billion JPY | 17.18% |
| 2014 | 4.07 Billion JPY | 1.18% |
| 2013 | 4.11 Billion JPY | 9.01% |
| 2012 | 4.8 Billion JPY | 8.46% |
| 2011 | 3.42 Billion JPY | -3.45% |
| 2010 | 3.57 Billion JPY | 26.17% |
| 2009 | 2.85 Billion JPY | -1.34% |
| 2008 | 2.81 Billion JPY | 10.87% |
| 2007 | 3.7 Billion JPY | 9.99% |
| 2006 | 2.53 Billion JPY | -12.51% |
| 2005 | 2.81 Billion JPY | 6.31% |
| 2004 | 1.61 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 60 Million JPY | -17.11% |
| 2024 Q2 | 1.1 Billion JPY | 1657.14% |
| 2023 Q2 | 1.14 Billion JPY | 4.67% |
| 2023 FY | - JPY | -41.32% |
| 2023 Q4 | 586 Million JPY | -54.08% |
| 2023 Q1 | 1.09 Billion JPY | 127.29% |
| 2023 Q3 | 1.27 Billion JPY | 11.73% |
| 2022 FY | - JPY | -8.04% |
| 2022 Q3 | 1.38 Billion JPY | -51.79% |
| 2022 Q4 | 480 Million JPY | -65.44% |
| 2022 Q2 | 2.88 Billion JPY | 1.16% |
| 2022 Q1 | 2.84 Billion JPY | 60.81% |
| 2021 Q2 | 2.26 Billion JPY | -14.01% |
| 2021 Q4 | 1.77 Billion JPY | -4.11% |
| 2021 Q3 | 1.84 Billion JPY | -18.42% |
| 2021 Q1 | 2.63 Billion JPY | 128.56% |
| 2021 FY | - JPY | 24.01% |
| 2020 FY | - JPY | 34.18% |
| 2020 Q1 | 1.03 Billion JPY | 239.47% |
| 2020 Q2 | 1.76 Billion JPY | 70.93% |
| 2020 Q3 | 2.86 Billion JPY | 62.53% |
| 2020 Q4 | 1.15 Billion JPY | -59.82% |
| 2019 Q1 | 1.51 Billion JPY | 340.12% |
| 2019 FY | - JPY | 1.02% |
| 2019 Q3 | 1.31 Billion JPY | -17.04% |
| 2019 Q4 | 304 Million JPY | -76.95% |
| 2019 Q2 | 1.59 Billion JPY | 5.02% |
| 2018 Q3 | 1.74 Billion JPY | 36.07% |
| 2018 FY | - JPY | 20.38% |
| 2018 Q1 | 1.32 Billion JPY | 9585.71% |
| 2018 Q2 | 1.28 Billion JPY | -3.54% |
| 2018 Q4 | 344 Million JPY | -80.26% |
| 2017 Q4 | -14 Million JPY | -101.06% |
| 2017 FY | - JPY | -7.62% |
| 2017 Q3 | 1.31 Billion JPY | 16.86% |
| 2017 Q2 | 1.12 Billion JPY | -0.7% |
| 2017 Q1 | 1.13 Billion JPY | 74.08% |
| 2016 FY | - JPY | 12.69% |
| 2016 Q4 | 652 Million JPY | -40.24% |
| 2016 Q3 | 1.09 Billion JPY | -14.43% |
| 2016 Q2 | 1.27 Billion JPY | 18.6% |
| 2016 Q1 | 1.07 Billion JPY | 52.92% |
| 2015 Q1 | 890 Million JPY | 26.96% |
| 2015 Q2 | 1.1 Billion JPY | 23.71% |
| 2015 FY | - JPY | 17.18% |
| 2015 Q4 | 703 Million JPY | -21.45% |
| 2015 Q3 | 895 Million JPY | -18.71% |
| 2014 Q2 | 1.14 Billion JPY | 39.98% |
| 2014 Q4 | 701 Million JPY | 91.53% |
| 2014 FY | - JPY | 1.18% |
| 2014 Q1 | 818 Million JPY | 66.94% |
| 2014 Q3 | 366 Million JPY | -68.03% |
| 2013 Q1 | 881 Million JPY | 197.64% |
| 2013 Q3 | 926 Million JPY | 12.65% |
| 2013 Q4 | 490 Million JPY | -47.08% |
| 2013 FY | - JPY | 9.01% |
| 2013 Q2 | 822 Million JPY | -6.7% |
| 2012 Q3 | 952 Million JPY | 32.41% |
| 2012 FY | - JPY | 8.46% |
| 2012 Q1 | 876 Million JPY | 1490.48% |
| 2012 Q2 | 719 Million JPY | -17.92% |
| 2012 Q4 | 296 Million JPY | -68.91% |
| 2011 Q3 | 915 Million JPY | -2.66% |
| 2011 Q1 | 772 Million JPY | -6.08% |
| 2011 FY | - JPY | -3.45% |
| 2011 Q2 | 940 Million JPY | 21.76% |
| 2011 Q4 | -63 Million JPY | -106.89% |
| 2010 Q4 | 822 Million JPY | -7.54% |
| 2010 FY | - JPY | 26.17% |
| 2010 Q3 | 889 Million JPY | -7.97% |
| 2010 Q2 | 966 Million JPY | -5.94% |
| 2010 Q1 | 1.02 Billion JPY | 105.81% |
| 2009 Q1 | 861 Million JPY | 57.12% |
| 2009 FY | - JPY | -1.34% |
| 2009 Q2 | 927 Million JPY | 7.67% |
| 2009 Q3 | 642 Million JPY | -30.74% |
| 2009 Q4 | 499 Million JPY | -22.27% |
| 2008 Q4 | 548 Million JPY | -17.22% |
| 2008 FY | - JPY | 10.87% |
| 2008 Q3 | 662 Million JPY | -15.24% |
| 2008 Q2 | 781 Million JPY | 0.0% |
| 2007 FY | - JPY | 9.99% |
| 2006 FY | - JPY | -12.51% |
| 2005 FY | - JPY | 6.31% |
| 2004 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| DVx Inc. | 807.98 Million JPY | -606.078% |
| Seikagaku Corporation | 2.09 Billion JPY | -172.185% |
| Create Medic Co., Ltd. | 1.39 Billion JPY | -310.021% |
| PHC Holdings Corporation | 39.08 Billion JPY | 85.404% |
| Techno Medica Co., Ltd. | 1.95 Billion JPY | -192.082% |
| Rion Co., Ltd. | 4.37 Billion JPY | -30.35% |
| Nihon Kohden Corporation | 23.44 Billion JPY | 75.666% |
| Fukuda Denshi Co., Ltd. | 36.23 Billion JPY | 84.254% |
| Japan Lifeline Co., Ltd. | 12.39 Billion JPY | 53.955% |
| Japan Medical Dynamic Marketing, INC. | 3.27 Billion JPY | -74.288% |
| 3-D Matrix, Ltd. | 2.09 Billion JPY | -172.706% |
| CYBERDYNE Inc. | -2 Million JPY | 285350.0% |